• Profile
Close

Colchicine therapy in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials

Coronary Artery Disease Jul 30, 2021

Al-Abdouh A, Barbarawi M, Khan SU, et al. - In this systematic review and meta-analysis, researchers analyzed randomized controlled trials (RCTs) assessing colchicine in coronary artery disease (CAD) patients. These studies were identified from PubMed/MEDLINE, Cochrane library, and Embase databases. Overall six RCTs with 6154 patients were analyzed. At the median follow-up of 3.5 months, colchicine use in CAD patients was not related to statistically significant decrease of major adverse cardiovascular events, myocardial infarction, all-cause death, cardiovascular death, and stroke. Thus, it was clear that colchicine therapy failed to confer a significant reduction in cardiovascular endpoints and mortality in patients suffering from CAD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay